This trial will compare the pain-relieving effects of a MTP block to a thoracic paravertebral block and to no block.
- Acute Pain
- Breast Cancer
1 Primary · 1 Secondary · Reporting Duration: 48 hours
3 Treatment Groups
1 of 3
MTP block group
1 of 3
1 of 3
150 Total Participants · 3 Treatment Groups
Primary Treatment: MTP block group · Has Placebo Group · N/A
Who is running the clinical trial?
Age 18 - 65 · Female Participants · 4 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Is senior participation accepted in this research endeavor?
"This medical trial necessitates that enrollees must be aged between 18 and 65. Alternately, there are 124 trials appropriate for individuals below the age of consent and 2706 studies available to those over retirement age." - Anonymous Online Contributor
Are any new participants being accepted into this experiment?
"Affirmative, the details on clinicaltrials.gov reveal that this investigation is currently seeking participants. This trial was first announced on January 1st 2020 and has recently been modified as of September 29th 2022. The research team needs to recruit 150 patients from one single site." - Anonymous Online Contributor
What criteria must be met for enrolment in this experiment?
"This medical trial seeks 150 participants, ranging in age from 18 to 65 years old and who have been diagnosed with breast cancer. Additionally, those wishing to participate must be scheduled for major surgery, classified as either ASA I-III on the physical status scale, and possess a BMI of below 30kg/m2." - Anonymous Online Contributor
What is the population size for this research undertaking?
"Affirmative. Clinicaltrials.gov's records reveal that the clinical trial, which was initially posted on January 1st 2020 and recently updated on September 29th 2022, is actively recruiting patients. This medical experiment requires 150 participants to be sourced from a single site." - Anonymous Online Contributor